Suppr超能文献

倍他米松治疗对控制营养期间碘甲状腺原氨酸和甲状腺激素结合蛋白的影响。一项关于慢性炎症性肠病患者的研究。

Effect of betamethasone treatment on iodothyronines and thyroid hormone-binding proteins during controlled nutrition. A study on patients with chronic inflammatory bowel disease.

作者信息

Gamstedt A, Järnerot G, Kågedal B

出版信息

Acta Endocrinol (Copenh). 1983 Jun;103(2):188-91. doi: 10.1530/acta.0.1030188.

Abstract

Forty patients with ulcerative colitis and Crohn's disease were divided into four groups. They were given betamethasone (6 mg daily) either iv or orally in combination with either iv or oral administration of nutrients. The glucocorticoid reduced the serum T4 significantly (11-16%) when the nutrition was given iv and the same trend occurred (7-9%) in the orally nutriated groups. Corticosteroids reduced the serum T3 by 20-39%, TSH 29-67%, delta TSH 45-76% and TBG 11-18% and increased the rT3 by 19-66% and the T3-uptake 6-16% irrespective of the mode of administration of the steroids although the changes did not reach statistical significance (P less than 0.05) in all groups. A significant increase of serum TBPA by 24% occurred only in the group receiving both steroids and nutrition iv with only minor or no changes (0-12%) in the other three groups. Except for the serum T4 the results were not influenced by the mode of nutrition (iv or oral).

摘要

40例溃疡性结肠炎和克罗恩病患者被分为四组。他们接受了倍他米松(每日6毫克)静脉注射或口服,并联合静脉或口服营养物质。当静脉给予营养时,糖皮质激素显著降低血清T4(11%-16%),口服营养组也出现相同趋势(7%-9%)。无论糖皮质激素的给药方式如何,其均可使血清T3降低20%-39%,TSH降低29%-67%,△TSH降低45%-76%,TBG降低11%-18%,并使rT3升高19%-66%,T3摄取升高6%-16%,尽管并非所有组的变化均达到统计学显著性(P<0.05)。仅在静脉给予糖皮质激素和营养物质的组中,血清TBPA显著升高24%,其他三组仅有轻微变化或无变化(0%-12%)。除血清T4外,结果不受营养方式(静脉或口服)的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验